Skip to content
Nottingham Technology Ventures Home Page
  • About us
  • Spin-out portfolio
    • Full portfolio
    • Healthcare
    • Agriculture & the environment
    • Materials & manufacturing
    • Digital
    • Exits
  • News
    • NTV news
    • Spin-out news
  • Contact us
  • About us
  • Spin-out portfolio
    • Full portfolio
    • Healthcare
    • Agriculture & the environment
    • Materials & manufacturing
    • Digital
    • Exits
  • News
    • NTV news
    • Spin-out news
  • Contact us

Sector: Healthcare

Biotech firm that ‘could revolutionise woundcare’ raises £1.8m

SurePulse announces new chairman

Funding boost for brain imaging in children with epilepsy

First patient dosed with a new eye drop to treat one of the leading causes of blindness

CognitOss Granted FDA Breakthrough Device Designation

Locate Bio appoints Keith Valentine as the Non-Executive Chair of the Board of Directors

New spin-out company signals quantum leap for brain imaging

UK wide study aims to relieve millions who suffer from dry eye syndrome

Locate Bio acquires complementary late stage orthobiologics assets, accelerating ambition of building a world leading, diversified orthobiologics company

Eye-sight saving tech designed by Nottingham healthcare experts could help cut post-Covid NHS waiting lists

Older posts
Newer posts
← Previous Page1 Page2 Page3 Page4 … Page8 Next →

© 2020 Nottingham Technology Ventures Limited.
All rights reserved.

Registered in England number 04477457
Registered office address

University Of Nottingham Kings Meadow Campus, Lenton Lane, Nottingham, England, NG7 2NR

Privacy Policy | Terms & Conditions | Cookies
Website by Clifton Media

Nottingham Technology Ventures Limited
The Ingenuity Centre
University of Nottingham Innovation Park
Triumph Road
Nottingham
NG7 2TU

  • [email protected]
  • +44 (0)115 823 2180
  • 2022 Annual Report (pdf)
  • 2021 Annual Report (pdf)